Edible Oil · Founded 1974 · www.modinaturals.com · BSE 519003 · NSE MODINATURAL · ISIN INE537F01012
No Notes Added Yet
Business
Modi Naturals Ltd. is an Indian company primarily engaged in the business of manufacturing, processing, and marketing edible oils and other food products. Its core business model involves sourcing raw edible oils and seeds, refining and processing them, and then branding and distributing them to end consumers and institutional clients. The company makes money by selling its range of packaged edible oils under various brands, including Nutri Planet (mustard oil, refined oils), Oleev (olive oil, pomace oil, extra virgin olive oil), Miller (rice bran oil), and PIPO (virgin coconut oil). It also operates in the oil extraction and refining of rice bran oil.
Revenue Mix
The company's primary revenue driver is the Edible Oil segment. Within this segment, it offers a diversified product portfolio across different oil types and price points:
Mustard Oil: A significant contributor under the Nutri Planet brand.
Refined Oils: Including sunflower, soyabean, and palm oils.
Olive Oil: A premium offering under the Oleev brand.
Rice Bran Oil: Marketed under the Miller brand, often positioned as a healthier alternative.
Virgin Coconut Oil: Under the PIPO brand.
While specific revenue percentages for each brand or oil type are not publicly detailed, the company's focus is predominantly on branded packaged edible oils, catering to both mass-market and premium segments.
Industry
Modi Naturals operates in the highly competitive and fragmented Indian Edible Oil industry. The market is characterized by high consumption, driven by population growth and dietary habits, but also significant price sensitivity and reliance on imports for raw materials. The industry includes large national players (e.g., Adani Wilmar, Patanjali Foods/Ruchi Soya), regional brands, and numerous unorganized players. Modi Naturals positions itself with a multi-brand strategy, targeting different consumer segments: Nutri Planet for mass-market staple oils, Oleev for the premium and health-conscious olive oil segment, and Miller for the growing rice bran oil category. It aims to carve out market share through brand building, product diversification, and distribution reach, particularly in North and Eastern India.
MOAT
Modi Naturals possesses some competitive advantages, though not as formidable as the industry giants:
Brand Portfolio: A diversified portfolio (Nutri Planet, Oleev, Miller, PIPO) allows it to cater to multiple consumer segments and price points, offering some resilience against competition in specific categories. Oleev, in particular, has established itself in the niche olive oil market in India.
Distribution Network: Over time, the company has built a distribution network crucial for reaching diverse consumer bases across various geographies in India.
Processing Capabilities: In-house refining and processing capabilities provide some control over quality and cost.
However, the overall moat is moderate due to low switching costs for consumers in the edible oil category and intense competition from larger, more scaled players.
Growth Drivers
Increasing Per Capita Consumption: Rising disposable incomes, urbanization, and a growing population in India are expected to drive overall demand for edible oils.
Shift to Branded Products: A gradual shift from unorganized/loose oils to packaged, branded oils due to increasing awareness of hygiene, quality, and health benefits.
Premiumization & Health Consciousness: Growing demand for healthier and premium oils like olive oil, rice bran oil, and specialized blended oils, where Modi Naturals has a presence (Oleev, Miller).
Distribution Expansion: Expanding its reach into new geographical markets and strengthening its existing distribution channels, especially in rural and semi-urban areas.
New Product Launches: Introduction of new value-added products or variations to cater to evolving consumer preferences.
Risks
Commodity Price Volatility: Significant fluctuations in the prices of raw edible oils and seeds (palm, soy, mustard) can impact profitability, as these are major input costs.
Intense Competition: The edible oil market is highly competitive, with large national players and regional brands vying for market share, leading to potential pricing pressures.
Regulatory Changes: Changes in government policies related to import duties, food safety standards, and agricultural subsidies can affect operations and costs.
Supply Chain Disruptions: Dependency on sourcing raw materials, including imports, makes the company vulnerable to global supply chain disruptions or geopolitical events.
Brand Perception & Quality Issues: Any compromise on product quality or safety could severely impact brand reputation and consumer trust in a sensitive product category like food.
Foreign Exchange Fluctuations: Given potential imports of crude oils or raw materials, adverse currency movements could increase costs.
Management & Ownership
Modi Naturals Ltd. is promoted by the Modi family. The company is led by Mr. Mukesh Kumar Modi (Managing Director) and Mr. Akshay Modi (Whole-time Director), representing the promoter group. The management is primarily promoter-driven, a common structure among Indian businesses. The ownership structure typically involves a significant stake held by the promoter group, ensuring aligned long-term vision, alongside a public float.
Outlook
Modi Naturals operates in an essential consumption category with tailwinds from India's demographic and economic growth, particularly the shift towards branded and healthier edible oils. The company's multi-brand strategy and focus on both mass-market and premium segments provide a diversified approach to capture growth. However, the business remains susceptible to high commodity price volatility and intense competition from larger, more established players with greater scale and deeper pockets. The company's ability to consistently innovate, strengthen its brand equity, efficiently manage its supply chain, and expand its distribution will be critical for sustained profitability and market share gains against these formidable industry challenges.
| #(Fig in Cr.) | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Sales | 120 | 148 | 147 | 179 | 190 | 155 | 147 | 174 | 243 | 156 |
| Other Income | 0 | 0 | 0 | 1 | 0 | 0 | 1 | 0 | 0 | -0 |
| Total Income | 120 | 148 | 147 | 180 | 190 | 155 | 148 | 174 | 243 | 155 |
| Total Expenditure | 114 | 134 | 133 | 166 | 174 | 137 | 132 | 158 | 219 | 133 |
| Operating Profit | 6 | 13 | 14 | 14 | 16 | 18 | 16 | 16 | 25 | 22 |
| Interest | 3 | 3 | 3 | 3 | 3 | 2 | 2 | 2 | 1 | 3 |
| Depreciation | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 3 |
| Exceptional Income / Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 5 | 0 |
| Profit Before Tax | 1 | 9 | 9 | 9 | 11 | 13 | 12 | 12 | 26 | 16 |
| Provision for Tax | 0 | 1 | 1 | 1 | 3 | 3 | 2 | 2 | 6 | 3 |
| Profit After Tax | 1 | 7 | 8 | 8 | 8 | 10 | 10 | 10 | 20 | 13 |
| Adjustments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -0 | 0 |
| Profit After Adjustments | 1 | 7 | 8 | 8 | 8 | 10 | 10 | 10 | 20 | 13 |
| Adjusted Earnings Per Share | 0.9 | 5.6 | 5.7 | 5.9 | 6.1 | 7.9 | 7.6 | 7.5 | 14.8 | 9.4 |
| #(Fig in Cr.) | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|
| Net Sales | 443 | 474 | 418 | 400 | 663 | 719 | 720 |
| Other Income | 4 | 1 | 2 | 1 | 1 | 1 | 1 |
| Total Income | 447 | 476 | 420 | 401 | 664 | 720 | 720 |
| Total Expenditure | 430 | 459 | 413 | 391 | 607 | 645 | 642 |
| Operating Profit | 17 | 16 | 7 | 10 | 57 | 75 | 79 |
| Interest | 1 | 2 | 4 | 7 | 12 | 8 | 8 |
| Depreciation | 1 | 1 | 2 | 4 | 8 | 8 | 9 |
| Exceptional Income / Expenses | 0 | 0 | 0 | 0 | 0 | 5 | 5 |
| Profit Before Tax | 14 | 13 | 2 | -2 | 38 | 64 | 66 |
| Provision for Tax | 3 | 4 | 1 | -0 | 7 | 13 | 13 |
| Profit After Tax | 11 | 9 | 1 | -1 | 31 | 50 | 53 |
| Adjustments | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit After Adjustments | 11 | 9 | 1 | -1 | 31 | 50 | 53 |
| Adjusted Earnings Per Share | 8.3 | 7.4 | 0.8 | -1 | 23.3 | 37.8 | 39.3 |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Sales CAGR | 8% | 20% | 10% | 0% |
| Operating Profit CAGR | 32% | 120% | 35% | 0% |
| PAT CAGR | 61% | 268% | 35% | 0% |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Share Price CAGR | -17% | 6% | 26% | 10% |
| ROE Average | 34% | 21% | 15% | 15% |
| ROCE Average | 24% | 15% | 12% | 13% |
| #(Fig in Cr.) | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Shareholder's Funds | 68 | 77 | 82 | 91 | 122 | 172 |
| Minority's Interest | 0 | 0 | 0 | 0 | 0 | 0 |
| Borrowings | 0 | 0 | 88 | 86 | 71 | 120 |
| Other Non-Current Liabilities | 5 | 5 | 5 | 4 | 8 | 11 |
| Total Current Liabilities | 48 | 83 | 88 | 126 | 130 | 103 |
| Total Liabilities | 121 | 165 | 263 | 306 | 330 | 407 |
| Fixed Assets | 19 | 26 | 27 | 149 | 145 | 214 |
| Other Non-Current Assets | 1 | 7 | 94 | 1 | 26 | 21 |
| Total Current Assets | 99 | 132 | 135 | 156 | 159 | 172 |
| Total Assets | 121 | 165 | 263 | 306 | 330 | 407 |
| #(Fig in Cr.) | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Opening Cash & Cash Equivalents | 1 | 0 | 4 | 2 | 0 | 0 |
| Cash Flow from Operating Activities | 9 | -13 | -6 | -7 | 49 | 61 |
| Cash Flow from Investing Activities | 2 | -13 | -91 | -32 | -28 | -72 |
| Cash Flow from Financing Activities | -12 | 30 | 95 | 37 | -21 | 12 |
| Net Cash Inflow / Outflow | -1 | 4 | -2 | -2 | -0 | 2 |
| Closing Cash & Cash Equivalent | 0 | 4 | 2 | 0 | 0 | 2 |
| # | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Earnings Per Share (Rs) | 8.31 | 7.4 | 0.84 | -1.04 | 23.32 | 37.79 |
| CEPS(Rs) | 9.4 | 8.52 | 2.07 | 2.13 | 29.19 | 43.81 |
| DPS(Rs) | 0 | 0 | 0 | 0 | 0 | 0 |
| Book NAV/Share(Rs) | 52.31 | 60.41 | 56.6 | 68.1 | 91.24 | 129.36 |
| Core EBITDA Margin(%) | 2.91 | 3.17 | 1.3 | 2.31 | 8.47 | 10.29 |
| EBIT Margin(%) | 3.49 | 3.15 | 1.35 | 1.43 | 7.47 | 9.99 |
| Pre Tax Margin(%) | 3.16 | 2.73 | 0.44 | -0.43 | 5.69 | 8.83 |
| PAT Margin (%) | 2.38 | 1.97 | 0.26 | -0.34 | 4.68 | 6.99 |
| Cash Profit Margin (%) | 2.69 | 2.27 | 0.63 | 0.71 | 5.86 | 8.11 |
| ROA(%) | 8.68 | 6.54 | 0.5 | -0.48 | 9.76 | 13.66 |
| ROE(%) | 15.88 | 13.13 | 1.44 | -1.7 | 29.27 | 34.26 |
| ROCE(%) | 17.82 | 13.94 | 3.26 | 2.39 | 18.68 | 23.8 |
| Receivable days | 17.28 | 15.37 | 16.77 | 21.34 | 20.66 | 23.95 |
| Inventory Days | 56.22 | 62.37 | 77.9 | 82.42 | 49.5 | 43.84 |
| Payable days | 8.23 | 10.19 | 17.55 | 28.27 | 21.01 | 21.68 |
| PER(x) | 8.79 | 26.62 | 276 | 0 | 14.67 | 7.56 |
| Price/Book(x) | 1.4 | 3.26 | 4.12 | 2.81 | 3.75 | 2.21 |
| Dividend Yield(%) | 0 | 0 | 0 | 0 | 0 | 0 |
| EV/Net Sales(x) | 0.25 | 0.62 | 1.04 | 1.06 | 0.91 | 0.74 |
| EV/Core EBITDA(x) | 6.66 | 18.07 | 60.33 | 42.58 | 10.48 | 7.11 |
| Net Sales Growth(%) | 0 | 7.14 | -11.88 | -4.34 | 65.8 | 8.49 |
| EBIT Growth(%) | 0 | -3.43 | -62.32 | 1.47 | 767.73 | 45 |
| PAT Growth(%) | 0 | -10.94 | -88.59 | -229 | 2350.85 | 62.07 |
| EPS Growth(%) | 0 | -10.94 | -88.59 | -222.71 | 2350.84 | 62.07 |
| Debt/Equity(x) | 0.31 | 0.67 | 1.99 | 1.87 | 1.23 | 0.94 |
| Current Ratio(x) | 2.06 | 1.59 | 1.53 | 1.24 | 1.22 | 1.66 |
| Quick Ratio(x) | 0.64 | 0.46 | 0.57 | 0.48 | 0.58 | 0.8 |
| Interest Cover(x) | 10.36 | 7.55 | 1.49 | 0.77 | 4.18 | 8.66 |
| Total Debt/Mcap(x) | 0.22 | 0.2 | 0.48 | 0.67 | 0.33 | 0.42 |
| # | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 69.09 | 69.09 | 69.09 | 69.09 | 69.09 | 69.09 | 69.09 | 69.09 | 69.09 | 69.09 |
| FII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| DII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Public | 30.91 | 30.91 | 30.91 | 30.91 | 30.91 | 30.91 | 30.91 | 30.91 | 30.91 | 30.91 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| # | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 0.92 | 0.92 | 0.92 | 0.92 | 0.92 | 0.92 | 0.92 | 0.92 | 0.92 | 0.92 |
| FII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| DII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Public | 0.41 | 0.41 | 0.41 | 0.41 | 0.41 | 0.41 | 0.41 | 0.41 | 0.41 | 0.41 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 1.33 | 1.33 | 1.33 | 1.33 | 1.33 | 1.33 | 1.33 | 1.33 | 1.33 | 1.33 |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Sales CAGR | +8% | +20% | +10% | — |
| Operating Profit CAGR | +32% | +120% | +35% | — |
| PAT CAGR | +61% | +268% | +35% | — |
| Share Price CAGR | -17% | +6% | +26% | +10% |
| ROE Average | +34% | +21% | +15% | +15% |
| ROCE Average | +24% | +15% | +12% | +13% |
| # | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 69.09 | 69.09 | 69.09 | 69.09 | 69.09 | 69.09 | 69.09 | 69.09 | 69.09 | 69.09 |
| FII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| DII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Public | 30.91 | 30.91 | 30.91 | 30.91 | 30.91 | 30.91 | 30.91 | 30.91 | 30.91 | 30.91 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| # | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 0.92 | 0.92 | 0.92 | 0.92 | 0.92 | 0.92 | 0.92 | 0.92 | 0.92 | 0.92 |
| FII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| DII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Public | 0.41 | 0.41 | 0.41 | 0.41 | 0.41 | 0.41 | 0.41 | 0.41 | 0.41 | 0.41 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 1.33 | 1.33 | 1.33 | 1.33 | 1.33 | 1.33 | 1.33 | 1.33 | 1.33 | 1.33 |
* The pros and cons are machine generated.
Our experts help you choose the right stocks based on performance, risk, and growth potential.
Looking to buy unlisted shares or need guidance on the investment process? Our expert Private Equity Advisors are here to assist you with accurate information, real-time pricing, and seamless execution.
Want to sell unlisted shares, liquidate your ESOPs, or understand the step-by-step process of liquidation? Connect with our Buying Team for smooth coordination, quick evaluations, and end-to-end support.
Planning to build or grow your portfolio? For Mutual Fund investments, PMS solutions, tailored portfolio creation, and overall wealth management, our dedicated Wealth Team is ready to guide you.
Your relationship manager will connect with you shortly.